{"transactions":[{"id":739904,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:28:32.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":16900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":16900,"derivative":{"exercise_price":23.3,"expiration_date":"2036-06-10","underlying":"Stock Option (Rights to Buy)","underlying_shares":16900},"source":{"system":"sec-edgar","filing":"0001770252-26-000003","document":"wk-form4_1781296109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000177025226000003/wk-form4_1781296109.xml","form_type":"4"}},{"id":739903,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:28:32.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 11, 2027 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":43000,"source":{"system":"sec-edgar","filing":"0001770252-26-000003","document":"wk-form4_1781296109.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000177025226000003/wk-form4_1781296109.xml","form_type":"4"}},{"id":1113503,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:27:57.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":38300,"derivative":{"exercise_price":10.02,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001724521-25-000086","document":"wk-form4_1749760070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452125000086/wk-form4_1749760070.xml","form_type":"4"}},{"id":1113502,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:27:57.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":37300,"source":{"system":"sec-edgar","filing":"0001724521-25-000086","document":"wk-form4_1749760070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452125000086/wk-form4_1749760070.xml","form_type":"4"}},{"id":1486867,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T22:19:56.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":24000,"derivative":{"exercise_price":15.9,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001724521-24-000110","document":"wk-form4_1717798788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000110/wk-form4_1717798788.xml","form_type":"4"}},{"id":1486866,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:19:56.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001724521-24-000110","document":"wk-form4_1717798788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000110/wk-form4_1717798788.xml","form_type":"4"}},{"id":1762971,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:19:20.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":7247,"price":15.01,"value":108777.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":223993,"source":{"system":"sec-edgar","filing":"0001770252-23-000009","document":"wk-form4_1696969151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000009/wk-form4_1696969151.xml","form_type":"4"}},{"id":1762970,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:19:20.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":4864,"price":15.01,"value":73008.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":231240,"source":{"system":"sec-edgar","filing":"0001770252-23-000009","document":"wk-form4_1696969151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000009/wk-form4_1696969151.xml","form_type":"4"}},{"id":1772857,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-09-27T20:27:48.000Z","date":"2023-09-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4402,"price":15.99,"value":70387.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023."}],"balance_after":236104,"source":{"system":"sec-edgar","filing":"0001770252-23-000007","document":"wk-form4_1695846455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000007/wk-form4_1695846455.xml","form_type":"4"}},{"id":1852387,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-17T00:11:09.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option becomes fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":19500,"derivative":{"exercise_price":19.6,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-23-038150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123038150/doc4.xml","form_type":"4"}},{"id":1852386,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-17T00:11:09.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":15600,"source":{"system":"sec-edgar","filing":"0001209191-23-038150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919123038150/doc4.xml","form_type":"4"}},{"id":1937323,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-28T21:23:44.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":6433,"price":23.48,"value":151046.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 9, 2022."}],"balance_after":240506,"source":{"system":"sec-edgar","filing":"0001770252-23-000004","document":"wf-form4_168003861168211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000004/wf-form4_168003861168211.xml","form_type":"4"}},{"id":1938397,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:27:41.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3124,"price":23.72,"value":74101.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":246939,"source":{"system":"sec-edgar","filing":"0001628280-23-009261","document":"wf-form4_167994884975705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009261/wf-form4_167994884975705.xml","form_type":"4"}},{"id":1938396,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:27:41.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2143,"price":23.72,"value":50831.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":250063,"source":{"system":"sec-edgar","filing":"0001628280-23-009261","document":"wf-form4_167994884975705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009261/wf-form4_167994884975705.xml","form_type":"4"}},{"id":1940670,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-23T20:28:15.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2419,"price":22.91,"value":55419.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023."}],"balance_after":252206,"source":{"system":"sec-edgar","filing":"0001628280-23-009047","document":"wf-form4_167960328178070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009047/wf-form4_167960328178070.xml","form_type":"4"}},{"id":1950942,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-16T20:31:22.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":39405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":254625,"source":{"system":"sec-edgar","filing":"0001628280-23-008322","document":"wf-form4_167899866500395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023008322/wf-form4_167899866500395.xml","form_type":"4"}},{"id":1976322,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-03T22:04:21.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":13184,"price":22.7414,"value":299822.6176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.97, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":215220,"source":{"system":"sec-edgar","filing":"0001770252-23-000002","document":"wf-form4_167788101472427.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000002/wf-form4_167788101472427.xml","form_type":"4"}},{"id":2070211,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-01-04T23:07:19.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":853,"price":14.51,"value":12377.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 30, 2022."}],"balance_after":228404,"source":{"system":"sec-edgar","filing":"0001770252-23-000001","document":"wf-form4_167287361378749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025223000001/wf-form4_167287361378749.xml","form_type":"4"}},{"id":2139691,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:34:13.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":7251,"price":19.62,"value":142264.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":229257,"source":{"system":"sec-edgar","filing":"0001628280-22-026250","document":"wf-form4_166552043913445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026250/wf-form4_166552043913445.xml","form_type":"4"}},{"id":2139690,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:34:13.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":4867,"price":19.62,"value":95490.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":236508,"source":{"system":"sec-edgar","filing":"0001628280-22-026250","document":"wf-form4_166552043913445.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026250/wf-form4_166552043913445.xml","form_type":"4"}},{"id":2150769,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:27.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":2950,"price":18.41,"value":54309.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022."}],"balance_after":241375,"source":{"system":"sec-edgar","filing":"0001628280-22-025566","document":"wf-form4_166431073246152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025566/wf-form4_166431073246152.xml","form_type":"4"}},{"id":2150768,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:27.000Z","date":"2022-09-25","kind":"tax_withholding","acquired":false,"shares":642,"price":18.69,"value":11998.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022."}],"balance_after":244325,"source":{"system":"sec-edgar","filing":"0001628280-22-025566","document":"wf-form4_166431073246152.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025566/wf-form4_166431073246152.xml","form_type":"4"}},{"id":2173330,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:22:59.000Z","date":"2022-08-25","kind":"tax_withholding","acquired":false,"shares":1132,"price":24.89,"value":28175.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2022."}],"balance_after":244967,"source":{"system":"sec-edgar","filing":"0001628280-22-023768","document":"wf-form4_166154535435807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022023768/wf-form4_166154535435807.xml","form_type":"4"}},{"id":2230007,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:25:00.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The option becomes fully vested and exercisable in the event the Company is subject to a change in control."}],"balance_after":16800,"derivative":{"exercise_price":20.62,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001209191-22-037414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122037414/doc4.xml","form_type":"4"}},{"id":2230006,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:25:00.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in full on the earlier of June 14, 2023 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control."}],"balance_after":4100,"source":{"system":"sec-edgar","filing":"0001209191-22-037414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919122037414/doc4.xml","form_type":"4"}},{"id":2318207,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:02:26.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":3178,"price":25.32,"value":80466.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":246099,"source":{"system":"sec-edgar","filing":"0001770252-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025222000006/edgardoc.xml","form_type":"4"}},{"id":2318206,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:02:26.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":2169,"price":25.32,"value":54919.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":249277,"source":{"system":"sec-edgar","filing":"0001770252-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025222000006/edgardoc.xml","form_type":"4"}},{"id":2320468,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-23T20:55:05.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":33665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":251446,"source":{"system":"sec-edgar","filing":"0001770252-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025222000004/edgardoc.xml","form_type":"4"}},{"id":2386450,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-02-18T22:14:09.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":43295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics.  On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025."}],"balance_after":217781,"source":{"system":"sec-edgar","filing":"0001770252-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025222000002/edgardoc.xml","form_type":"4"}},{"id":2477781,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-10T21:39:47.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 317 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on November 1, 2021."}],"balance_after":174486,"source":{"system":"sec-edgar","filing":"0001770252-21-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000019/edgardoc.xml","form_type":"4"}},{"id":2544931,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-12T20:46:00.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":7470,"price":30.88,"value":230673.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021."}],"balance_after":164169,"source":{"system":"sec-edgar","filing":"0001770252-21-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000015/edgardoc.xml","form_type":"4"}},{"id":2544930,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-12T20:46:00.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":5013,"price":30.88,"value":154801.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021."}],"balance_after":171639,"source":{"system":"sec-edgar","filing":"0001770252-21-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000015/edgardoc.xml","form_type":"4"}},{"id":2553012,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-04T20:16:45.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1420,"price":31.5736,"value":44834.512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.91 to $32.01, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":176652,"source":{"system":"sec-edgar","filing":"0001770252-21-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000013/edgardoc.xml","form_type":"4"}},{"id":2559328,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-28T01:13:55.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":10112,"price":33.1039,"value":334746.6368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.43 to $33.62, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":178072,"source":{"system":"sec-edgar","filing":"0001770252-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000011/edgardoc.xml","form_type":"4"}},{"id":2559327,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-28T01:13:55.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":3426,"price":33.31,"value":114120.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":188184,"source":{"system":"sec-edgar","filing":"0001770252-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000011/edgardoc.xml","form_type":"4"}},{"id":2559326,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-28T01:13:55.000Z","date":"2021-09-25","kind":"tax_withholding","acquired":false,"shares":1311,"price":33.31,"value":43669.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":191610,"source":{"system":"sec-edgar","filing":"0001770252-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000011/edgardoc.xml","form_type":"4"}},{"id":2561263,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-23T21:24:40.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":65870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics.  On September 21, 2021, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":192921,"source":{"system":"sec-edgar","filing":"0001770252-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000009/edgardoc.xml","form_type":"4"}},{"id":2587379,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-30T20:11:46.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":945,"price":34.5,"value":32602.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":127051,"source":{"system":"sec-edgar","filing":"0001770252-21-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000007/edgardoc.xml","form_type":"4"}},{"id":2590055,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-27T01:55:59.000Z","date":"2021-08-25","kind":"tax_withholding","acquired":false,"shares":1123,"price":34.81,"value":39091.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021."}],"balance_after":127996,"source":{"system":"sec-edgar","filing":"0001770252-21-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000005/edgardoc.xml","form_type":"4"}},{"id":2613064,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T20:28:18.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":21700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable in 36 equal monthly installments after August 3, 2021, subject to the Reporting Person's continued service to the Company."}],"balance_after":21700,"derivative":{"exercise_price":30.02,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":21700},"source":{"system":"sec-edgar","filing":"0001209191-21-049938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919121049938/doc4.xml","form_type":"4"}},{"id":2613063,"issuer":{"id":4104,"kind":"organization","name":"Arcus Biosciences, Inc."},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T20:28:18.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units that vest in three equal annual installments on each of September 15, 2022, September 15, 2023, and September 15, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":4700,"source":{"system":"sec-edgar","filing":"0001209191-21-049938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724521/000120919121049938/doc4.xml","form_type":"4"}},{"id":2744358,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-20T21:18:30.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":5890,"price":27.0095,"value":159085.955,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.13, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129119,"source":{"system":"sec-edgar","filing":"0001770252-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000004/edgardoc.xml","form_type":"4"}},{"id":2744357,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-20T21:18:30.000Z","date":"2021-04-19","kind":"sale","acquired":false,"shares":759,"price":27.0089,"value":20499.7551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.13, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":135009,"source":{"system":"sec-edgar","filing":"0001770252-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000004/edgardoc.xml","form_type":"4"}},{"id":2771105,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Oncology,"}}],"security":"Common Stock","published_at":"2021-03-26T20:19:52.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":29556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":135768,"source":{"system":"sec-edgar","filing":"0001770252-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025221000002/edgardoc.xml","form_type":"4"}},{"id":3008750,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-10-13T12:14:41.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":44211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":106212,"source":{"system":"sec-edgar","filing":"0001770252-20-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000010/edgardoc.xml","form_type":"4"}},{"id":3019136,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-10-01T21:38:14.000Z","date":"2020-09-30","kind":"disposition_to_issuer","acquired":false,"shares":591,"price":13.04,"value":7706.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":62001,"source":{"system":"sec-edgar","filing":"0001770252-20-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000008/edgardoc.xml","form_type":"4"}},{"id":3021920,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-09-28T16:59:16.000Z","date":"2020-09-26","kind":"disposition_to_issuer","acquired":false,"shares":2935,"price":12.44,"value":36511.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":62592,"source":{"system":"sec-edgar","filing":"0001770252-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000006/edgardoc.xml","form_type":"4"}},{"id":3021919,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-09-28T16:59:16.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":628,"price":12.44,"value":7812.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":65527,"source":{"system":"sec-edgar","filing":"0001770252-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000006/edgardoc.xml","form_type":"4"}},{"id":3021918,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-09-28T16:59:16.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":13,"price":12.44,"value":161.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":66155,"source":{"system":"sec-edgar","filing":"0001770252-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000006/edgardoc.xml","form_type":"4"}},{"id":3021917,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-09-28T16:59:16.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":628,"price":12.44,"value":7812.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":66168,"source":{"system":"sec-edgar","filing":"0001770252-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000006/edgardoc.xml","form_type":"4"}},{"id":3056444,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-08-17T20:33:02.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":7646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022."}],"balance_after":66796,"source":{"system":"sec-edgar","filing":"0001770252-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000004/edgardoc.xml","form_type":"4"}},{"id":3278158,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2020-02-12T23:28:50.000Z","date":"2020-02-12","kind":"sale","acquired":false,"shares":4354,"price":19.7324,"value":85914.8696,"ownership":{"direct":true},"balance_after":59150,"source":{"system":"sec-edgar","filing":"0001770252-20-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025220000002/edgardoc.xml","form_type":"4"}},{"id":3403668,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-10-01T22:20:21.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":591,"price":28.63,"value":16920.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":63504,"source":{"system":"sec-edgar","filing":"0001770252-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000006/edgardoc.xml","form_type":"4"}},{"id":3403667,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-10-01T22:20:21.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":591,"price":28.63,"value":16920.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":64095,"source":{"system":"sec-edgar","filing":"0001770252-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000006/edgardoc.xml","form_type":"4"}},{"id":3406005,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-09-26T20:54:52.000Z","date":"2019-09-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023."}],"balance_after":64686,"source":{"system":"sec-edgar","filing":"0001770252-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000004/edgardoc.xml","form_type":"4"}},{"id":3406004,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-09-26T20:54:52.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":628,"price":29.93,"value":18796.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":24686,"source":{"system":"sec-edgar","filing":"0001770252-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000004/edgardoc.xml","form_type":"4"}},{"id":3406003,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-09-26T20:54:52.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":628,"price":29.93,"value":18796.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":25314,"source":{"system":"sec-edgar","filing":"0001770252-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000004/edgardoc.xml","form_type":"4"}},{"id":3406002,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":38758,"kind":"person","name":"Lambert Nicole","position":1,"cik":"0001770252","reported_name":"Lambert Nicole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, MGL"}}],"security":"Common Stock","published_at":"2019-09-26T20:54:52.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":13,"price":29.93,"value":389.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":25942,"source":{"system":"sec-edgar","filing":"0001770252-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000177025219000004/edgardoc.xml","form_type":"4"}}]}